Open Source Imaging Consortium (OSIC)
OSIC – a global, 501(c)(3), not-for-profit cooperative effort between academia, industry and patient advocacy groups – was created to enable rapid, open source advances in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases, including emphysematous conditions.
OSIC brings together radiologists, clinicians, computational scientists, and industry competitors from around the world to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.
The partners work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients.
On its way to becoming the largest and most diverse ILD database in the world
15,000 anonymized scans with accompanying clinical data
COMMITTED TO DATE
20,375 anonymized scans with accompanying clinical data
Predicting lung function decline
The OSIC Pulmonary Fibrosis Progression challenged the world’s brightest data science minds to predict lung function decline by using AI machine learning.